인메드 파마슈티컬스 (INM) 주가

인메드 파마슈티컬스(INM)는 NASDAQ에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $1.38 (-0.72%), 시가총액 $0.01B, 52주 최저~최고 $0.61 ~ $3.87.

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with unmet medical needs. The company's lead product consists of INM-755, a cannabinol top

핵심 지표

• 현재가: $1.38 (-0.72%)
• 시가총액: $0.01B
• 52주 최저~최고: $0.61 ~ $3.87
• 섹터: Healthcare
• 산업: Drug Manufacturers - Specialty & Generic
• 거래소: NASDAQ

인메드 파마슈티컬스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

인메드 파마슈티컬스 재무 요약

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.77
• 순이익률: -1.72%
• 영업이익률: -1.63%

자주 묻는 질문